What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Virus
- Cancer
Philippe Halfon mostly deals with Internal medicine, Gastroenterology, Fibrosis, Hepatitis C virus and FibroTest.
His study looks at the relationship between Internal medicine and fields such as Viral load, as well as how they intersect with chemical problems.
His research integrates issues of Biopsy, Liver biopsy and Predictive value of tests in his study of Gastroenterology.
His research on Hepatitis C virus is centered around Virology and Immunology.
The study incorporates disciplines such as Protease inhibitor and Reverse transcriptase in addition to Virology.
Within one scientific family, Philippe Halfon focuses on topics pertaining to Alcoholic liver disease under FibroTest, and may sometimes address concerns connected to Chronic liver disease and Biomarker.
His most cited work include:
- Drug-resistance genotyping in HIV-1 therapy: the VIRAD APT randomi sed controlled trial (687 citations)
- Meta-analyses of FibroTest diagnostic value in chronic liver disease (256 citations)
- CpG methylation controls reactivation of HIV from latency. (253 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of investigation include Virology, Internal medicine, Hepatitis C virus, Immunology and Gastroenterology.
His Virology research includes elements of RNA and Genotype.
His work deals with themes such as Chronic hepatitis and Oncology, which intersect with Internal medicine.
He has included themes like Hepatitis C and Alpha interferon in his Hepatitis C virus study.
His biological study spans a wide range of topics, including Liver disease and Liver function tests.
His research in Virus intersects with topics in Reverse transcriptase and Hepatitis.
He most often published in these fields:
- Virology (41.10%)
- Internal medicine (33.05%)
- Hepatitis C virus (31.78%)
What were the highlights of his more recent work (between 2014-2021)?
- Internal medicine (33.05%)
- Virology (41.10%)
- Viral load (16.53%)
In recent papers he was focusing on the following fields of study:
His main research concerns Internal medicine, Virology, Viral load, Immunology and Cancer research.
His Internal medicine research includes themes of Gastroenterology and Oncology.
He combines subjects such as Ribavirin and Boceprevir with his study of Gastroenterology.
His Virology study combines topics in areas such as Dolutegravir, Hiv infected patients and DNA sequencing.
His studies in Viral load integrate themes in fields like Reverse transcription polymerase chain reaction, Hepatitis C virus, Cervical cancer, Real-time polymerase chain reaction and Hepatitis B virus.
His Hepatitis C virus study frequently links to related topics such as Cirrhosis.
Between 2014 and 2021, his most popular works were:
- HCV kinetic and modeling analyses indicate similar time to cure among sofosbuvir combination regimens with daclatasvir, simeprevir or ledipasvir (48 citations)
- IL‐22 and IL‐22 binding protein (IL‐22BP) regulate fibrosis and cirrhosis in hepatitis C virus and schistosome infections (43 citations)
- Point-of-Care Versus Central Laboratory Measurements of Hemoglobin, Hematocrit, Glucose, Bicarbonate and Electrolytes: A Prospective Observational Study in Critically Ill Patients. (27 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Virus
- Cancer
Philippe Halfon focuses on Internal medicine, Immunology, Hepatitis C, Hepatitis C virus and NS5A.
Philippe Halfon interconnects Surgery and Viral load in the investigation of issues within Internal medicine.
As a part of the same scientific study, he usually deals with the Hepatitis C, concentrating on Ribavirin and frequently concerns with Gastroenterology.
His Hepatitis C virus research is multidisciplinary, relying on both Interleukin and Cirrhosis.
His studies deal with areas such as Regimen and Drug resistance as well as NS5A.
The Ledipasvir study which covers Fixed-dose combination that intersects with Virology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
